Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Sort descending Title Grant Number Initiative Program Official
Hansen, Laura A

Creighton University
United States

Targeting aberrant anti-apoptotic signaling for prevention of skin cancer 5R01CA253573-05 Howard L. Parnes, M.D.
Ahn, Eun Hyun

Johns Hopkins University
United States

Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents 5R01CA279948-02 Guillermo Marquez, Ph.D.
Borges, Chad R

Arizona State University-Tempe Campus
United States

Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions 5R21CA269091-03 RFA-CA-21-005 (R21 Clinical Trial Not Allowed) Indu Kohaar, Ph.D., M.Phil., M.Sc.
Simeone, Diane M

University Of California, San Diego
United States

Biomarker Validation in Pancreatic Cystic Neoplasms 5U01CA282272-03 PAR-21-334 (U01 Clinical Trial Optional) Matthew Young, Ph.D.
Kumar, Nagi B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Phase II Clinical trial of GTC in Men on Active Surveillance 5R01CA235032-06 Howard L. Parnes, M.D.
Kelleher, Sarah

Duke University
United States

Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients 5R01CA291888-02 Brennan Streck, Ph.D., RN, M.P.H.
Leal, Ana Sofia Mendes

Indiana University Indianapolis
United States

Nrf2, immune cells and lung cancer 7R01CA226690-06 Marjorie Perloff, M.D.
Jobin, Christian

University Of Florida
United States

Interaction between dietary taurine and microbiota sulfur metabolism in the development of colorectal cancer 5R01CA296643-02 Young Kim, Ph.D.
Barber, Glen N.

Ohio State University
United States

Development of A HTLV-1 Vaccine 7R01CA252049-05 Marjorie Perloff, M.D.
Skubitz, Amy Patrice

University Of Minnesota
United States

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection 5R01CA262153-05 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Christos Patriotis, Ph.D., M.Sc.